))
Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers
Manage episode 497618663 series 3680875
Content provided by Roy Castle Lung Cancer Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roy Castle Lung Cancer Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Lorraine Dallas, our director of prevention, information and support, chats to consultant oncologist Dr David Gilligan and Peter Cowley, who is living with advanced stage lung cancer.
Therapies are available for some lung cancers driven by genetic mutations or rearrangements, which is why biomarker testing is so important. Peter shares his experience of diagnosis and being eligible for one of these medicines.
For more information about lung cancer and Roy Castle Lung Cancer Foundation, visit roycastle.org.
Keep up to date with the latest news by following our social media channels:
Twitter - Roy_Castle_Lung
Instagram - RoyCastleLungCancer
Facebook - Roy Castle Lung Cancer Foundation
49 episodes
Share
